3HP-2827

3HP-2827 · 3H (Suzhou) Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 3HP-2827, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations [Phase 1, Phase 2]

See pricing